Revised SPCs: Zofran (ondansetron) preparations
Section 5.3 now includes information from embryo-foetal development studies in rats and rabbits, which did not show evidence of harm to the foetus when ondansetron was administered during the period of organogenesis.
Source:
electronic Medicines compendium